These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 15628299

  • 1. [Type I insulin-like growth factor receptor antisense strategies in experimental breast cancer].
    Salatino M, Schillaci R, Proietti CJ, Carnevale R, Charreau EH, Elizalde PV.
    Medicina (B Aires); 2004; 64(2):129-34. PubMed ID: 15628299
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M, Schillaci R, Proietti CJ, Carnevale R, Frahm I, Molinolo AA, Iribarren A, Charreau EH, Elizalde PV.
    Oncogene; 2004 Jul 01; 23(30):5161-74. PubMed ID: 15122317
    [Abstract] [Full Text] [Related]

  • 3. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
    Balañá ME, Lupu R, Labriola L, Charreau EH, Elizalde PV.
    Oncogene; 1999 Nov 04; 18(46):6370-9. PubMed ID: 10597237
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
    Adachi Y, Li R, Yamamoto H, Min Y, Piao W, Wang Y, Imsumran A, Li H, Arimura Y, Lee CT, Imai K, Carbone DP, Shinomura Y.
    Carcinogenesis; 2009 Aug 04; 30(8):1305-13. PubMed ID: 19493905
    [Abstract] [Full Text] [Related]

  • 5. Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo.
    Chernicky CL, Yi L, Tan H, Gan SU, Ilan J.
    Cancer Gene Ther; 2000 Mar 04; 7(3):384-95. PubMed ID: 10766344
    [Abstract] [Full Text] [Related]

  • 6. [Growth hormones and oncogenes in mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice].
    Elizalde PV, Balaña ME, Charreau EH.
    Medicina (B Aires); 1997 Mar 04; 57 Suppl 2():70-4. PubMed ID: 9580484
    [Abstract] [Full Text] [Related]

  • 7. Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells.
    Balañá ME, Labriola L, Salatino M, Movsichoff F, Peters G, Charreau EH, Elizalde PV.
    Oncogene; 2001 Jan 04; 20(1):34-47. PubMed ID: 11244498
    [Abstract] [Full Text] [Related]

  • 8. Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines.
    Nakamura K, Hongo A, Kodama J, Miyagi Y, Yoshinouchi M, Kudo T.
    Cancer Res; 2000 Feb 01; 60(3):760-5. PubMed ID: 10676665
    [Abstract] [Full Text] [Related]

  • 9. TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
    Rivas MA, Carnevale RP, Proietti CJ, Rosemblit C, Beguelin W, Salatino M, Charreau EH, Frahm I, Sapia S, Brouckaert P, Elizalde PV, Schillaci R.
    Exp Cell Res; 2008 Feb 01; 314(3):509-29. PubMed ID: 18061162
    [Abstract] [Full Text] [Related]

  • 10. Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo.
    Tanno B, Mancini C, Vitali R, Mancuso M, McDowell HP, Dominici C, Raschellà G.
    Clin Cancer Res; 2006 Nov 15; 12(22):6772-80. PubMed ID: 17121898
    [Abstract] [Full Text] [Related]

  • 11. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ, Kong MJ, Ma ZY, Qian JF, Fan JQ, Xu XH.
    Zhonghua Yi Xue Za Zhi; 2007 Jun 05; 87(21):1506-9. PubMed ID: 17785094
    [Abstract] [Full Text] [Related]

  • 12. Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor.
    Surmacz E.
    Oncogene; 2003 Sep 29; 22(42):6589-97. PubMed ID: 14528284
    [Abstract] [Full Text] [Related]

  • 13. Immunization with murine breast cancer cells treated with antisense oligodeoxynucleotides to type I insulin-like growth factor receptor induced an antitumoral effect mediated by a CD8+ response involving Fas/Fas ligand cytotoxic pathway.
    Schillaci R, Salatino M, Cassataro J, Proietti CJ, Giambartolomei GH, Rivas MA, Carnevale RP, Charreau EH, Elizalde PV.
    J Immunol; 2006 Mar 15; 176(6):3426-37. PubMed ID: 16517711
    [Abstract] [Full Text] [Related]

  • 14. Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation.
    Salatino M, Beguelin W, Peters MG, Carnevale R, Proietti CJ, Galigniana MD, Vedoy CG, Schillaci R, Charreau EH, Sogayar MC, Elizalde PV.
    Oncogene; 2006 Dec 14; 25(59):7723-39. PubMed ID: 16799639
    [Abstract] [Full Text] [Related]

  • 15. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
    Wang Z, Chakravarty G, Kim S, Yazici YD, Younes MN, Jasser SA, Santillan AA, Bucana CD, El-Naggar AK, Myers JN.
    Clin Cancer Res; 2006 Aug 01; 12(15):4755-65. PubMed ID: 16899627
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417.
    Haluska P, Carboni JM, Loegering DA, Lee FY, Wittman M, Saulnier MG, Frennesson DB, Kalli KR, Conover CA, Attar RM, Kaufmann SH, Gottardis M, Erlichman C.
    Cancer Res; 2006 Jan 01; 66(1):362-71. PubMed ID: 16397250
    [Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
    Barnes CJ, Ohshiro K, Rayala SK, El-Naggar AK, Kumar R.
    Clin Cancer Res; 2007 Jul 15; 13(14):4291-9. PubMed ID: 17634559
    [Abstract] [Full Text] [Related]

  • 18. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells.
    Fang J, Zhou Q, Shi XL, Jiang BH.
    Carcinogenesis; 2007 Mar 15; 28(3):713-23. PubMed ID: 17065200
    [Abstract] [Full Text] [Related]

  • 19. [Effect of IGF1 receptor gene antisense oligodeoxynucleotide on T24 urinary bladder cancer cells].
    Sun H, Fan J, Tang X.
    Zhonghua Zhong Liu Za Zhi; 2000 Jul 15; 22(4):276-8. PubMed ID: 11778548
    [Abstract] [Full Text] [Related]

  • 20. Characterization of a novel primary mammary tumor cell line reveals that cyclin D1 is regulated by the type I insulin-like growth factor receptor.
    Jones RA, Campbell CI, Petrik JJ, Moorehead RA.
    Mol Cancer Res; 2008 May 15; 6(5):819-28. PubMed ID: 18505926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.